p.94 抽出テキスト

procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998;31: 1414–1419. 453. Bianconi L, Castro A, Dinelli M, Alboni P, Pappalardo A, Richiardi E, et al. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. Eur Heart J 2000;21:1265–1273. 454. Kerola T, Dewland TA, Vittinghoff E, Heckbert SR, Stein PK, Marcus GM. Modifiable predictors of ventricular ectopy in the community. J Am Heart Assoc 2018;7:e010078. 455. Yang J, Dudum R, Mandyam MC, Marcus GM. Characteristics of unselected highburden premature ventricular contraction patients. Pacing Clin Electrophysiol 2014;37:1671–1680. 456. Parreira L, Marinheiro R, Amador P, Mesquita D, Farinha J, Lopes A, et al. Frequent premature ventricular contractions. Association of burden and complexity with prognosis according to the presence of structural heart disease. Ann Noninvasive Electrocardiol 2021;26:e12800. 457. Agarwal V, Vittinghoff E, Whitman IR, Dewland TA, Dukes JW, Marcus GM. Relation between ventricular premature complexes and incident heart failure. Am J Cardiol 2017;119:1238–1242. 458. Dukes JW, Dewland TA, Vittinghoff E, Mandyam MC, Heckbert SR, Siscovick DS, et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol 2015;66:101–109. 459. Marcus GM. Evaluation and management of premature ventricular complexes. Circulation 2020;141:1404–1418. 460. Mukharji J, Rude RE, Poole WK, Gustafson N, Thomas LJ, Jr., Strauss HW, et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol 1984;54:31–36. 461. Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL, et al. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverterdefibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2013;61:2161–2168. 462. Makimoto H, Zielke S, Clasen L, Lin T, Gerguri S, Muller P, et al. Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients. Eur J Med Res 2020;25:5. 463. Sanchez Munoz JJ, Garcia-Alberola A, Martinez-Sanchez J, Penafiel-Verdu P, Caro-Martinez C, Manzano-Fernandez S, et al. Premature ventricular complexes as a trigger for ventricular fibrillation. Rev Esp Cardiol 2010;63:798–801. 464. Kakishita M, Kurita T, Matsuo K, Taguchi A, Suyama K, Shimizu W, et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:1646–1653. 465. Srivathsan K, Gami AS, Ackerman MJ, Asirvatham SJ. Treatment of ventricular fibrillation in a patient with prior diagnosis of long QT syndrome: importance of precise electrophysiologic diagnosis to successfully ablate the trigger. Heart Rhythm 2007;4:1090–1093. 466. Almendral J, Villacastin JP, Arenal A, Tercedor L, Merino JL, Delcan JL. Evidence favoring the hypothesis that ventricular arrhythmias have prognostic significance in left ventricular hypertrophy secondary to systemic hypertension. Am J Cardiol 1995;76:60D–63D. 467. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015;36: 2793–2867. 468. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006;295:165–171. 469. Brodine WN, Tung RT, Lee JK, Hockstad ES, Moss AJ, Zareba W, et al. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol 2005;96:691–695. 470. Tilz RR, Lenarczyk R, Scherr D, Haugaa KH, Iliodromitis K, Purerfellner H, et al. Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey. Europace 2018;20:209–213. 471. Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. 2019 HRS/ EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace 2019;21:1143–1144. 472. Scheuermeyer FX, Grafstein E, Stenstrom R, Innes G, Heslop C, MacPhee J, et al. Thirty-day and 1-year outcomes of emergency department patients with atrial fibrillation and no acute underlying medical cause. Ann Emerg Med 2012;60: 755–765.e752. 473. Bonfanti L, Annovi A, Sanchis-Gomar F, Saccenti C, Meschi T, Ticinesi A, et al. Effectiveness and safety of electrical cardioversion for acute-onset atrial fibrillation in the emergency department: a real-world 10-year single center experience. Clin Exp Emerg Med 2019;6:64–69. 474. Kheiri B, Barbarawi M, Zayed Y, Hicks M, Osman M, Rashdan L, et al. Antiarrhythmic drugs or catheter ablation in the management of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Circ Arrhythm Electrophysiol 2019;12:e007600. 475. Santangeli P, Muser D, Maeda S, Filtz A, Zado ES, Frankel DS, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverterdefibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm 2016;13:1552–1559. 476. Martinez BK, Baker WL, Konopka A, Giannelli D, Coleman CI, Kluger J, et al. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm 2020;17:e206–e219. 477. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657–2665. 478. Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016; 375:111–121. 479. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacretaz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010;375:31–40. 480. Briceno DF, Gupta T, Romero J, Kolte D, Khera S, Villablanca PA, et al. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: a propensity score-matched analysis of in-hospital outcomes in the United States. J Cardiovasc Electrophysiol 2018;29:771–779. 481. Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021;42:3427–3520. 482. Marti-Almor J, Cladellas M, Bazan V, Delclos J, Altaba C, Guijo MA, et al. Novel predictors of progression of atrioventricular block in patients with chronic bifascicular block. Rev Esp Cardiol 2010;63:400–408. 483. Santini M, Castro A, Giada F, Ricci R, Inama G, Gaggioli G, et al. Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: the PRESS study. Circ Arrhythm Electrophysiol 2013;6: 101–107. 484. Stone ME, Salter B, Fischer A. Perioperative management of patients with cardiac implantable electronic devices. Br J Anaesth 2011;107:i16–i26. 485. Cardiac implantable electronic device management (corrected). Anesthesiology 2020;132:225–252. 486. Gifford J, Larimer K, Thomas C, May P. ICD-ON Registry for perioperative management of CIEDs: most require no change. Pacing Clin Electrophysiol 2017;40: 128–134. 487. Mahlow WJ, Craft RM, Misulia NL, Cox JW, Jr., Hirsh JB, Snider CC, et al. A perioperative management algorithm for cardiac rhythm management devices: the PACED-OP protocol. Pacing Clin Electrophysiol 2013;36:238–248. 488. Neubauer H, Wellmann M, Herzog-Niescery J, Wutzler A, Weber TP, Mugge A, et al. Comparison of perioperative strategies in ICD patients: the perioperative ICD management study (PIM study). Pacing Clin Electrophysiol 2018;41:1536–1542. 489. Feldman JB, Stone ME. Anesthesia teams managing pacemakers and ICDs for the perioperative period: enhanced patient safety and improved workflows. Curr Opin Anaesthesiol 2020;33:441–447. 490. Mickus GJ, Soliman GI, Reed RR, Martin AK. Perioperative management of a leadless pacemaker: the paucity of evidence-based guidelines. J Cardiothorac Vasc Anesth 2016;30:1594–1598. 491. Karuppiah S, Prielipp R, Banik RK. Anesthetic consideration for patients with micra leadless pacemaker. Ann Card Anaesth 2020;23:493–495. 492. Gifford J, Larimer K, Thomas C, May P, Stanhope S, Gami A. Randomized controlled trial of perioperative ICD management: magnet application versus reprogramming. Pacing Clin Electrophysiol 2014;37:1219–1224. 493. Winter J, Kohlmeier A, Shin DI, O’Connor S. Subcutaneous implantable cardioverter-defibrillators and sternal wires: a cautionary tale. Circ Arrhythm Electrophysiol 2014;7:986–987. 494. Schulman PM, Treggiari MM, Yanez ND, Henrikson CA, Jessel PM, Dewland TA, et al. Electromagnetic interference with protocolized electrosurgery dispersive electrode positioning in patients with implantable cardioverter defibrillators. Anesthesiology 2019;130:530–540. 495. Baeg MK, Kim SW, Ko SH, Lee YB, Hwang S, Lee BW, et al. Endoscopic electrosurgery in patients with cardiac implantable electronic devices. Clin Endosc 2016;49: 176–181.

ESC Guidelines                                                                                                                                                                                     3919

Downloaded from academic.oup.com/eurheartj/article/43/39/3826/6675076 by guest on 07 October 2026